Photo of Saul Priceman from Caryn Lerman/LinkedIn
Jun 15, 2024, 07:37
Saul Priceman: Phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC
Saul Priceman, Associate Professor at City of Hope, made the following post on X:
“Proud of our work published today in Nature Medicine, sharing results from our phase 1 trial with PSCA-CAR T cell therapy in patients with mCRPC. Big collaborations work Tanya Dorff, Stephen Forman, Peter Kuhn, Lior Pachter! Thank you Prostate Cancer Foundation for your support!”
Read further.
Source: Saul Priceman/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 17:57
Nov 14, 2024, 17:46
Nov 14, 2024, 17:46
Nov 14, 2024, 17:42
Nov 14, 2024, 17:14